StonvexLoading…
StonvexStonvexStonvexCore line items from NCMI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-02 | Annual 2026 2026-01-01 | Q3 2025 2025-09-25 | Q2 2025 2025-06-26 |
|---|---|---|---|---|
Revenue | $34.00M | $243.20M | $150.00M | $86.60M |
Operating Income | $-26.90M | $-13.90M | $-37.70M | $-35.90M |
Net Income | $-28.60M | $-10.60M | $-39.90M | $-41.40M |
EPS (Diluted) | $-0.31 | $-0.11 | $-0.42 | $-0.44 |
Total Assets | $468.70M | $490.60M | $451.90M | $462.00M |
Total Liabilities | $123.90M | $115.20M | $101.40M | $112.00M |
Cash & Equivalents | $48.60M | $34.60M | $29.90M | $37.20M |
Free Cash Flow OCF − CapEx | $17.80M | $2.80M | $-3.30M | $-1.30M |
Shares Outstanding | 93.57M | 93.35M | 93.72M | 93.42M |